Surface Dose in Head and Neck cancer treatment using MOSFET
Not Applicable
Not yet recruiting
- Registration Number
- CTRI/2020/07/026428
- Lead Sponsor
- Department of Radiotherapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
HEAD AND NECK CARCINOMA PLANS
Exclusion Criteria
NOT APPLICABLE
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Surface DoseTimepoint: 2 months
- Secondary Outcome Measures
Name Time Method ATimepoint: NA
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie surface dose measurement using MOSFET in head and neck cancer radiotherapy?
How does MOSFET-based surface dose monitoring compare to standard dosimetry methods in head and neck cancer treatment?
Are there specific biomarkers that correlate with radiation dose distribution in head and neck cancer patients using MOSFET technology?
What are the potential adverse events associated with MOSFET-guided radiation therapy for head and neck cancers and their management strategies?
What are the implications of CTRI/2020/07/026428 findings on the development of advanced dosimetry systems for head and neck cancer treatment?